DOUBLE TROUBLE: RITUXIMAB AND BENDAMUSTINE CHEMOTHERAPY-INDUCED PULMONARY HYPERTENSION FOLLOWING TREATMENT OF NODAL MARGINAL ZONE LYMPHOMA

被引：0
|
作者：
Geller, Andrew
Manzano, Jose Manuel Martinez
Sarvottam, Kumar
机构：
来源：
CHEST | 2024年 / 166卷 / 04期
关键词：
D O I：
10.1016/j.chest.2024.06.3418
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5752A / 5753A
页数：2
相关论文
共 18 条
  • [1] Frontline Bendamustine and Rituximab in Extra-Nodal Marginal Zone Lymphoma: A Single-Institution Experience
    Logothetis, Constantine
    Horvat, Nathan
    Kurian, Tony
    Bello, Celeste
    Chavez, Julio
    Isenalumhe, Leidy
    Shah, Bijal
    Sokol, Lubomir
    Saeed, Hayder
    Pinilla, Javier
    Gaballa, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S405 - S405
  • [2] Bendamustine-Rituximab Does Not Improve Survival over Rituximab Monotherapy for Older Patients with Nodal or Splenic Marginal Zone Lymphoma
    Olszewski, Adam J.
    Ollila, Thomas A.
    Reagan, John L.
    BLOOD, 2019, 134
  • [3] 2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma
    Orciuolo, Enrico
    Buda, Gabriele
    Sordi, Elisabetta
    Barate, Claudia
    Galimberti, Sara
    Ciancia, Eugenio
    Petrini, Mario
    LEUKEMIA RESEARCH, 2010, 34 (02) : 184 - 189
  • [4] The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma
    Laribi, Kamel
    Tempescul, Adrien
    Ghnaya, Habib
    Denizon, Nathalie
    Besancon, Anne
    Anghel, Andreea
    Farhi, Jonathan
    Truong, Catherine
    Lemaire, Pierre
    Poulain, Stephanie
    Bolle, Delphine
    Ianotto, Jean Christophe
    de Materre, Alix Baugier
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 536 - 541
  • [5] Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life
    Mulas, Olga
    Caocci, Giovanni
    Dessi, Daniela
    Mantovani, Daniela
    Moi, Giulia
    Cabras, Maria Giuseppina
    La Nasa, Giorgio
    ACTA HAEMATOLOGICA, 2021, 144 (03) : 322 - 326
  • [6] Chemotherapy-Induced Pulmonary Arterial Hypertension in an Infant with T-Lymphoblastic Lymphoma
    Inoue, Shun
    Oh, Yukiko
    Kawahara, Yuta
    Oka, Kensuke
    Hayase, Tomomi
    Kawada, Masaaki
    Oshiro, Hisashi
    Masaki, Naoki
    Ogawa, Aiko
    Shinno, Yoko
    Morimoto, Akira
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S55 - S55
  • [7] Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma
    Robinson, Adam C.
    Nachar, Victoria R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1248 - 1253
  • [8] CHEMOTHERAPY-INDUCED ENCEPHALOPATHY IN A PATIENT WITH RELAPSED MARGINAL ZONE B CELL LYMPHOMA WITH CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT
    Theprungsirikul, Poy
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S215 - S215
  • [9] Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study
    Iannitto, Emilio
    Bellei, Monica
    Ferreri, Andres J. M.
    Marcheselli, Luigi
    Cesaretti, Marina
    Haioun, Corinne
    Mancuso, Salvatrice
    Bouabdallah, Krimo
    Gressin, Remy
    Tripodo, Claudio
    Traverse-Glehen, Alexandra
    Baseggio, Lucile
    Zupo, Simonetta
    Stelitano, Caterina
    Castagnari, Barbara
    Patti, Caterina
    Merli, Francesco
    Liberati, Anna Marina
    Merli, Michele
    Gini, Guido
    Cabras, Maria Giuseppina
    Dupuis, Jehan
    Re, Francesca
    Zucca, Emanuele
    Federico, Massimo
    Thieblemont, Catherine
    BLOOD, 2017, 130
  • [10] Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine
    Manner, Hendrik
    Jung, Bernd
    Tonassi, Leonhard
    Hackenberg, Ulrich
    Plum, Nicola
    Josten, Klaus M.
    Kirchmaier, Carl M.
    Frickhofen, Norbert
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 335 (05): : 394 - 397
12